Advertisement
The Essential Resource for the Medical Design Engineering Community
Subscribe to MDT Magazine All

LuxteL Brand Is the Longest Standing Recognized Name in the Industry

December 28, 2010 10:35 am | by Bio-Medicine.Org | News | Comments

DANVERS, Mass., Dec. 28, 2010 /- LuxteL llc , a quality manufacturer of reliable illumination products made in the USA, announces that, with the recent sale of their only remaining manufacturing competitor, LuxteL is now the oldest recognized name in the Ceramic Lighting business. Since...

TOPICS:

Crothall Healthcare Selects 3Mâ„¢ Clean-Traceâ„¢ for Infection Control Verification

December 28, 2010 10:35 am | by Bio-Medicine.Org | News | Comments

WAYNE, Pa., Dec. 28, 2010 /- Crothall Healthcare, a premier provider of support services to healthcare clients, announced its Preferred Partnership arrangement with 3M to kick-off its powerfully enhanced approach to infection control. Crothall Environmental Services teams will use a...

TOPICS:

New Program for Medicare Beneficiaries Will Mean Major Changes Effective January 1, 2011

December 28, 2010 10:34 am | News | Comments

LUBBOCK, Texas, Dec. 28, 2010 /- The MED Group, a Managed Health Care Associates, Inc. (MHA) Company, announces the creation of www.medicaresuppliersnetwork.com .  The website was created to help answer questions for Medicare beneficiaries and referral sources, such as physician...

Advertisement

MIT scientists develop bladder disease device

December 28, 2010 9:37 am | by Mass High Tech: The Journal of New England Technology | News | Comments

MIT researchers have developed a pretzel-shaped device designed to treat interstitial cystitis, a bladder disease noted for causing frequent and painful urination predominantly in women, the MIT News Office reported Monday.

Miss. hospital to acquire second medical center

December 28, 2010 8:46 am | by The Associated Press | News | Comments

Anderson Regional Medical Center has completed its purchase of Riley Hospital from Health Management Associates Inc.Both hospitals are located in Meridian. Terms of the purchase were not released Tuesday.Anderson president/CEO L. Ray Humphreys says the acquisition is expected to be finalized by...

FDA warns Smith & Nephew over orthopedic plant

December 28, 2010 8:45 am | by The Associated Press | News | Comments

The Food and Drug Administration has issued a warning letter to orthopedic maker Smith & Nephew PLC over manufacturing problems uncovered at a plant in Germany earlier this year.Government inspectors visited the company's Tuttlingen, Germany plant in July and cited the company for several...

Spencer Pharmaceutical adds Buschmann to science board

December 28, 2010 8:37 am | by Mass High Tech: The Journal of New England Technology | News | Comments

Spencer Pharmaceutical Inc., a metabolic disease-focused firm in Boston, has appointed Michael Buschmann, director of the FRSQ Group in Biomedical Science and Technology, to Spencer's scientific advisory board.

HeartWare seeks FDA nod for heart device

December 28, 2010 8:36 am | by Mass High Tech: The Journal of New England Technology | News | Comments

HeartWare International Inc. has submitted its Ventricular Assist System to the U.S. Food and Drug Administration for Pre-Market Approval (PMA) as a bridge to heart transplantation for patients with end-stage heart failure, the company reported today.

Advertisement

Allscripts Sunrise Electronic Health Record Receives ONC-ATCB 2011/2012 Certification as 'Complete EHR'

December 28, 2010 8:36 am | by Bio-Medicine.Org | News | Comments

CHICAGO, Dec. 28, 2010 /- Allscripts (Nasdaq: MDRX ) announced today that Sunrise Acute Care, Version 5.5 and Sunrise Emergency Care Version 5.5 are 2011/2012 CCHIT compliant and were certified as Complete EHRs on December 21, 2010 by the Certification Commission for Health Information...

TOPICS:

Accuray Incorporated's CEO to Speak at 29th Annual J.P. Morgan Healthcare Conference

December 28, 2010 8:35 am | by Bio-Medicine.Org | News | Comments

SUNNYVALE, Calif., Dec. 28, 2010 /- Accuray Incorporated (Nasdaq: ARAY ), a global leader in the field of radiosurgery, announced today that its president and chief executive officer, Euan S. Thomson, Ph.D., is scheduled to present at the 29th Annual J.P. Morgan Healthcare Conference in...

TOPICS:

ASU technology to treat chronic respiratory diseases

December 28, 2010 8:34 am | by Arizona State University | News | Comments

Miniature sensor technology developed at ASU's Biodesign Institute will be used to develop medical devices to better treat chronic respiratory diseases such as asthma.read more

TOPICS:

Purdue, NIST working on breathalyzers for medical diagnostics

December 28, 2010 8:33 am | by EurekAlert | News | Comments

(Purdue University) Researchers have overcome a fundamental obstacle in developing breath-analysis technology to rapidly diagnose patients by detecting chemical compounds called "biomarkers" in a person's respiration in real time.

TOPICS:

Tivorsan makes key DMD therapy development

December 28, 2010 7:34 am | by Mass High Tech: The Journal of New England Technology | News | Comments

Tivorsan Pharmaceuticals, a protein therapeutics firm in Providence, R.I., has shown that mice with Duchenne Muscular Dystrophy have had improved muscle function due to biglycan protein, according to a news release today from the company.

Case Western Reserve receives $10M to study retinal disease, develop new treatments

December 28, 2010 6:40 am | by EurekAlert | News | Comments

(Case Western Reserve University) The Departments of Pharmacology and Ophthalmology and Visual Sciences at Case Western Reserve University School of Medicine have been awarded a $10.1 million grant from the National Eye Institute to research and develop new treatments for diseases...

TOPICS:

Federal Register: Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Medical Devices; Third Party Review Program...(3)

December 28, 2010 6:39 am | by U.S. Food & Drug Administration | News | Comments

Section 210 of the FDAMA established section 523 of the FD&C Act (21 U.S.C. 360m), directing FDA to accredit persons in the private sector to review certain premarket notifications (510(k)s). Participation in this third-party review program by...

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading